Publication

Impact immediate treatment interruption of secukinumab efficacy in patients with active psoriatic arthritis and ankylosing spondylitis: interim analysis results from the SERENA study

Gullick, Nicola
; 
Gullick, Nicola
Abstract
Not available
MIDER Authors
Citations
Altmetric:
Date
2022
Type
Article
Subject
Collections
UHCW Rheumatology
Learning Alerts
Posters
Show all metadata
Citation
Gaffney K, Kiltz U, Sfikakis P, Gullick N, et al. Impact immediate treatment interruption of secukinumab efficacy in patients with active psoriatic arthritis and ankylosing spondylitis: interim analysis results from the SERENA study. Rheumatology 61(s1) April 2022
Journal / Source Title
DOI
URI
http://hdl.handle.net/20.500.14200/4680
PMID
Publisher
Rheumatology
Rheumatology
Publisher’s URL
Publisher’s statement
Note / Copyright